Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,046
-
Share change
-
+34,046
-
Total reported value
-
$1,252,000
-
Price per share
-
$36.73
-
Number of holders
-
10
-
Value change
-
+$1,252,000
-
Number of buys
-
10
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q3 2017
As of 30 Sep 2017,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,046 shares.
The largest 10 holders included
Spark Investment Management LLC, HIGHLAND CAPITAL MANAGEMENT LP, MORGAN STANLEY, O'SHAUGHNESSY ASSET MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, LADENBURG THALMANN FINANCIAL SERVICES INC., Advisor Group, Inc., UBS Group AG, and ROYAL BANK OF CANADA.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.